SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-025001
Filing Date
2021-05-06
Accepted
2021-05-06 16:19:04
Documents
59
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q crtx-10q_20210331.htm   iXBRL 10-Q 2412363
2 EX-31.1 crtx-ex311_7.htm EX-31.1 17908
3 EX-31.2 crtx-ex312_8.htm EX-31.2 17991
4 EX-32.1 crtx-ex321_6.htm EX-32.1 10316
5 EX-32.2 crtx-ex322_9.htm EX-32.2 10381
  Complete submission text file 0001564590-21-025001.txt   8147987

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA crtx-20210331.xsd EX-101.SCH 41315
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crtx-20210331_cal.xml EX-101.CAL 41615
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crtx-20210331_def.xml EX-101.DEF 144584
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE crtx-20210331_lab.xml EX-101.LAB 336451
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crtx-20210331_pre.xml EX-101.PRE 264600
11 EXTRACTED XBRL INSTANCE DOCUMENT crtx-10q_20210331_htm.xml XML 1715815
Mailing Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 415-910-5717
Cortexyme, Inc. (Filer) CIK: 0001662774 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38890 | Film No.: 21898075
SIC: 2836 Biological Products, (No Diagnostic Substances)